Transformative Tech Unveiled at CES Asia 2018 on Opening Day
CES Asia® 2018 opened today, with more than 500 global companies introducing transformative innovation, including the latest in 5G, artificial intelligence (AI), augmented/virtual reality (AR/VR), vehicle tech and more. Opening day of Asia’s premier tech event featured keynotes from the leaders of Hisense, Huawei and BYTON, and major product announcements designed for the dynamic Asian marketplace. One of Asia’s fastest growing tradeshows, CES Asia 2018 runs through June 15 in Shanghai, China.
Gary Shapiro, president and CEO, Consumer Technology Association (CTA)TM, kicked off the day with a keynote address. “We’re proud to bring the entire tech ecosystem together this week in Shanghai to focus on the future of tech,” said Shapiro. “The innovations on the show floor create disruption, but also provide solutions. Self-driving vehicles can stop fatalities; AI is making us safer and healthier and drones are helping in disaster relief.” He continued, “CES Asia focuses on what unites us rather than on what divides us.”
Following Shapiro’s remarks, Hisense Chairman Zhou Houjian and General Manager Yu Zhitao explored the future of display technology explaining how Hisense is creating a full-field view search interactive function, opening a new era of television image interaction. Zhou also touted its new AI technology developed specifically for the World Cup, which will provide an individualized, interactive experience for sports fans across the world.
Huawei, President, Handset Product Line, Mr. Kevin Ho, took the keynote stage in the afternoon to introduce its vision for a new image era in mobile technology, including its cutting-edge lens technology, 5G internet capability and the advanced GPU Turbo processor. Ho also launched Huawei’s “Next Image Awards,” competition.
CES Asia 2018’s first day ended with BYTON President & Co-Founder Dr. Daniel Kirchert and Henrik Wenders, vice president of Marketing, using the keynote stage to share the company’s vision of the future of self-driving cars. The session also marked the global reveal of BYTON’s K-Byte Concept car, which will transform the auto industry in the age of smart mobility.
The buzz around tech breakthroughs expanded beyond the keynote stage. In his 2018 Tech Trends to Watch presentation, Steve Koenig, vice president, CTA, predicted how leading trends, including AI, voice computing, robotics, self-driving vehicles, smart devices and more will impact our lives and offer unprecedented opportunities. CTA’s Market Research Director, Lesley Rohrbaugh, also tackled the future of smart cities and how they are evolving throughout Asia with a specific focus on China, Japan and South Korea.
Pre-show and opening day of CES Asia featured a wide array of dynamic press events, with exciting product and partnership announcements coming from CES Asia exhibitors, aimed at improving the user experience and bettering lives:
- BYTON launched its second concept car, the Byton K-Byte, designed for the age of self-driving and in-vehicle entertainment
- Cadillac presented the Super Cruise, the first hands-free driving system for the highway
- Honda announced the Honda Xcelerator project, which aims to cooperate with innovative enterprises worldwide
- Kia announced its Boundless for all vision, which aims to provide customers with broader solutions and reinforce its concept of “Mobility-ACE”
- Leapmotor Technology announced a strategic partnership with the Amap and Teld. Amap will provide support to Leapmotor inhardware, software, and big data, while Teld and Leapmotor Technology will jointly build 80 million charging stations in China
- The Mercedes-Benz - MBUX, user experience system based on artificial intelligence technology, as well as high-resolution Digital Light system with more than two million light sources. With its new vision of urban mobility, the smart vision EQ fortwo was on display with the Concept EQ, showcasing intelligent, electric mobility concept
- Mitsubishi offered attendees the unique opportunity to experience three of its innovative offerings, including EMIRAI4, Electrification and xAuto
- SENSEPLAY FPV Car Series took the number one slot in Last Gadget Standing, presented by Living in Digital Times
The CES Asia 2018 conference program tackles technologies ranging from 5Gconnectivity to blockchain and runs through Friday, June 15 at the Shanghai New International Exhibition Centre (SNIEC) and Kerry Hotel. For the latest news, photos, b-roll and more, visit CESAsia.com.
Owned and produced by International CES (Shanghai) Exhibition Co. Ltd. and co-produced by Shanghai Intex, CES Asia 2018 concludes June 15, in Shanghai, China. The premier event for the consumer technology industry in Asia, CES Asia showcases major brands and innovative companies across several vertical markets in the Asian marketplace.
About CES Asia:
Owned and produced by the International CES (Shanghai) Exhibition Co. Ltd. and co-produced by Shanghai Intex Exhibition Co., Ltd (Shanghai Intex), CES Asia is the premier event for the consumer technology industry, showcasing the full breadth and depth of the innovation value-chain in the Asian marketplace. Key global businesses come to this new event to grow and reinforce their brand by showcasing the latest products and technologies to consumer tech industry executives, foreign buyers, international media and a limited number of consumers from China. Attendees have exclusive access to some of the largest brands from China and around the world, while celebrating the innovation that defines the consumer technology sector.
About International CES (Shanghai) Exhibition Co. Ltd. and CTA:
International CES (Shanghai) Exhibition Co. Ltd. is a wholly foreign-owned enterprise by the Consumer Technology Association (CTA), a trade association representing the $351 billion U.S. consumer technology industry, which supports more than 15 million U.S. jobs. More than 2,200 companies – 80 percent are small businesses and startups; others are among the world’s best known brands – enjoy the benefits of CTA membership including policy advocacy, market research, technical education, industry promotion, standards development and the fostering of business and strategic relationships. CTA also owns and produces CES® – the world’s gathering place for all who thrive on the business of consumer technologies. Profits from CES are reinvested into CTA’s industry services.
About Shanghai Intex:
Shanghai Intex Exhibition Co., Ltd was originally the exhibition organizing business of Shanghai Intex, a pioneering exhibition organizer established in 1995. Shanghai Intex is jointly overseen by the China Council for the Promotion of International Trade (CCPIT) Shanghai and PNO Exhibition Investment (Dubai) Limited. Starting in 1998, Shanghai Intex has organized over 100 trade shows and conferences with a sum total exhibition space in excess of 2 million sqm. Shanghai Intex is comprised of professional teams with a wealth of experience in organizing major international events, covering the creative industry, healthcare, lifestyle, advanced manufacturing and consumer electronics.
CES Asia 2018 –
June 13-15, Shanghai, China
June 24-27, Barcelona, Spain
CES Unveiled Amsterdam
September 27, Amsterdam, Netherlands
Tech & Standard Fall Forum
October 1-5, Hollywood, CA
CES Unveiled Paris
October 3, Paris, France
October 15-17, Boston, MA
CES Unveiled New York
November 8, New York, NY
CES Unveiled Las Vegas
January 6, 2019, Las Vegas, NV
January 8-11, 2019, Las Vegas, NV
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza16.8.2018 08:00 | Tiedote
BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease, today announced that it has entered into a multi-year research and development (R&D) collaboration with Pfizer Inc. (NYSE: PFE) to develop mRNA-based vaccines for prevention of influenza (flu). Under the terms of the agreement, BioNTech and Pfizer will jointly conduct research and development activities to help advance mRNA-based flu vaccines. Pfizer will assume sole responsibility for further clinical development and commercialization of mRNA-based flu vaccines, following BioNTech’s completion of a first in human clinical study. BioNTech will receive $120 million in upfront, equity and near-term research payments and up to an additional $305 million in potential development, regulatory and commercial milestone payments. In addition, BioNTech will receive up to double-digit tiered royalty payments associated with worldwide sales if the program reac
Maxion Wheels to Showcase Market-Leading Light Weight Commercial Vehicle Wheels at REIFEN 201816.8.2018 07:05 | Tiedote
Maxion Wheels, the world’s largest producer of wheels, announced today its participation in REIFEN, the leading tire and wheel industry event in Europe, from Sept. 11 – 15, 2018 in Hall 12.1 / Stand D24. For the first time, REIFEN will be co-located with Automechanika Frankfurt at the Messe Frankfurt. “REIFEN is the premier event for European tire and wheel manufacturers and resellers, bringing us together to meet and collaborate on the important aftermarket themes of innovation, service and delivery,” stated Mark Gerardts, Vice President of Global Sales and Marketing, Maxion Wheels. “After a highly popular launch to truck and trailer OEMs in 2017, we’re excited to have the industry’s lightest mass production steel wheel now available to our aftermarket distributors. This wheel, along with several others, including our new 10.00W-20 wide base tubetype and tubeless heavy duty armored vehicles wheel are great examples of our continued efforts to bring our OE multi-application innovations
Lenovo Accelerates Turnaround with Back-to-Back, Double-Digit Quarterly Revenue Growth16.8.2018 02:40 | Tiedote
Lenovo Group (HKSE: 0992) (PINK SHEETS: LNVGY) today announced results for its first fiscal quarter ended June 30, 2018. For the second straight quarter, Lenovo achieved strong double-digit growth in revenue year-on-year. Group revenue reached US$11.91 billion, up 19% year-on-year. The company also reported strong pre-tax income during the quarter of US$113 million, an improvement of US$182 million year-on-year, as profitability improved across all businesses. In the first fiscal quarter, Lenovo’s profit attributable to equity holders grew to US$77 million, up US$149 million year-over-year. Basic earnings per share in the first fiscal quarter was 0.65 US cents or 5.10 HK cents. “As we persistently execute our 3-wave strategy, all our businesses made solid improvements in both revenue and profitability. Lenovo has passed the turning point and entered a phase of ‘acceleration’ - accelerating the execution of our transformation strategy and accelerating the rising momentum in business per
CORRECTING and REPLACING Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy16.8.2018 01:37 | Tiedote
Please replace the release with the following corrected version due to multiple revisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) The corrected release reads: EBOLA SUCCESSFULLY NEUTRALIZED BY LATEST GENERATION POLYCLONAL IMMUNOTHERAPY Promising new platform can rapidly respond to emerging infectious diseases Sioux Falls, SD, August 15, 2018 – SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted at the Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of He
QConnect – Markkinoiden älykkäin, erittäin kompakti ja lujatekoinen viestintälaite15.8.2018 23:23 | Tiedote
Quake Global, Inc. (QUAKE), yksi maailman johtavista IoT-markkinoiden toimittajista, julkaisi QConnect™, uuden sukupolven kehittyneen telematiikkalaitteen. Äärimmäisen kompakti QConnect integroituu kiinteisiin ja liikkuviin omaisuuksiin niiden seuraamiseksi, valvomiseksi ja hallitsemiseksi reaaliajassa mistä ja milloin tahansa. Laite tarjoaa useita pitkälle kehitettyjä langattomia kommunikaatiovaihtoehtoja, mukaan lukien LTE/2G/3G, kaksitaajuus-Wi-Fi, Bluetooth/BLE, V2X ja satelliitti. Laite on suunniteltu vastaamaan moniin eri vaatimuksiin yksinkertaisista ja edullisista seurantasovelluksista aina korkean suorituskyvyn monikanavaisiin videon suoratoistosovelluksiin. Tämä lehdistötiedote sisältää multimediaa. Katso koko julkaisu täällä: https://www.businesswire.com/news/home/20180815005706/fi/ Quake Global’s new QConnect, the most intelligent, global, ultra-compact and rugged communication device available (Photo: Business Wire) QConnect tarjoaa joustavuutta sen ainutlaatuisilla sovell
Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 20:43 | Tiedote
SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted by the National Interagency Confederation for Biological Research and other collaborators including United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) According to the World Health Organization, Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans with an average fatality rate around 50%.
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme